Skip to main content
. 2015 Mar 20;6:36. doi: 10.3389/fendo.2015.00036

Figure 4.

Figure 4

Pathway for estrogen-induced ASC1 ufmylation for ERα transactivation. “DRUG” indicates any small molecule that can act as a therapeutic anti-breast cancer drug by blocking ASC1 ufmylation.